2-(2-fluorobenzyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide | 127511-41-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 2-(2-fluorobenzyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide
• 英文别名: 2-(2-fluorobenzyl)-1,2-benzothiazol-3(2H)-one 1,1-dioxide；2-[(2-fluorophenyl)methyl]-1,1-dioxo-1,2-benzothiazol-3-one
• CAS: 127511-41-5
• 化学式: C₁₄H₁₀FNO₃S
• 分子量: 291.303
• InChiKey: SRFKAWSSVKPPFF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  62.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(2-fluorobenzyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide 在 potassium tert-butylate 、 乙酸酐 作用下， 以 二甲基亚砜 为溶剂， 反应 6.0h， 生成 Ethyl 2-cyano-2-[3-cyano-2-[(2-fluorophenyl)methyl]-1,1-dioxo-1,2-benzothiazol-3-yl]acetate
  参考文献：
  名称：

  Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents

  摘要：

  Compounds from two novel series of spirosuccinimides were prepared. Analogs of series 2 possessed a spiro-fused isoindolone moiety while those of series 3 contained a spiro-fused benzisothiazole S,S-dioxide group. These compounds were evaluated as aldose reductase inhibitors (ARI) in vitro by their ability to inhibit glyceraldehyde reduction using a partially purified bovine lens aldose reductase preparation and in vivo as inhibitors of galactitol accumulation in the lens, sciatic nerve, and diaphragm of galactose-fed rats. Many members from the isoindolone series 2, particularly those containing an isoindolone N-methyl moiety, showed good in vitro and in vivo potency. The most potent member, the 6-chloro analog 32, was resolved, and aldose reductase activity was found to reside almost exclusively in the (+)-enantiomer. Compound 32 was approximately equipotent in the sciatic nerve of the galactose-fed rat to other cyclic imide ARI's of similar in vitro activity, namely sorbinil and ADN-138 and also to tolrestat, an acetic acid-based ARI (ED50's 4-8 mg/kg). Compounds from both series, 2 and 3, were also found to lower plasma glucose levels of genetically obese db/db and ob/ob mice with potency similar to that of ciglitazone. However, members from these series failed to lower insulin levels of the ob/ob mouse at the doses tested.

  DOI：

  10.1021/jm00102a016
• 作为产物：
  描述：

  saccharin sodium salt 生成 2-(2-fluorobenzyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide
  参考文献：
  名称：

  WROEL, JAY E.

  摘要：

  DOI：

文献信息

• Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII
  作者：Melissa D’Ascenzio、Simone Carradori、Celeste De Monte、Daniela Secci、Mariangela Ceruso、Claudiu T. Supuran

  DOI：10.1016/j.bmc.2014.01.056

  日期：2014.3

  antitumor carbonic anhydrase inhibitors (CAIs), the obtained results represent an encouraging achievement for the development of new anticancer candidates without the common side effects of non-selective CAIs. Moreover, the lack of an explicit zinc binding function on these inhibitors opens the way towards the exploration of novel mechanisms of inhibition that could explain the high selectivity of these

  合成了一系列N-烷基化糖精衍生物，并测试了其对人碳酸酐酶的四种不同同工型的抑制作用（CA，EC 4. 2.1.1）：跨膜肿瘤相关的CA IX和XII，以及胞质CA I和二。大多数报道的衍生物在纳摩尔/低微摩尔范围内抑制CA XII，hCA IX的K I在11至390 nM之间，而对CA I（K I s> 50μM）和II（K I范围介于39.1 nM和50μM之间。由于CA I和II是抗肿瘤碳酸酐酶抑制剂（CAI）的脱靶靶标，因此获得的结果代表了开发新型抗癌候选药物的令人鼓舞的成就，而没有非选择性CAI的常见副作用。此外，在这些抑制剂上缺乏明确的锌结合功能为探索新的抑制机制开辟了道路，这可能解释了这些化合物对跨膜，与肿瘤相关的同工型相对于胞浆的同工型的高选择性。
• WROBEL, JAY E.
  作者：WROBEL, JAY E.

  DOI：——

  日期：——
• Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents
  作者：Jay Wrobel、Arlene Dietrich、Shiela A. Woolson、Jane Millen、Michael McCaleb、Maria C. Harrison、Thomas C. Hohman、Janet Sredy、Donald Sullivan

  DOI：10.1021/jm00102a016

  日期：1992.11

  Compounds from two novel series of spirosuccinimides were prepared. Analogs of series 2 possessed a spiro-fused isoindolone moiety while those of series 3 contained a spiro-fused benzisothiazole S,S-dioxide group. These compounds were evaluated as aldose reductase inhibitors (ARI) in vitro by their ability to inhibit glyceraldehyde reduction using a partially purified bovine lens aldose reductase preparation and in vivo as inhibitors of galactitol accumulation in the lens, sciatic nerve, and diaphragm of galactose-fed rats. Many members from the isoindolone series 2, particularly those containing an isoindolone N-methyl moiety, showed good in vitro and in vivo potency. The most potent member, the 6-chloro analog 32, was resolved, and aldose reductase activity was found to reside almost exclusively in the (+)-enantiomer. Compound 32 was approximately equipotent in the sciatic nerve of the galactose-fed rat to other cyclic imide ARI's of similar in vitro activity, namely sorbinil and ADN-138 and also to tolrestat, an acetic acid-based ARI (ED50's 4-8 mg/kg). Compounds from both series, 2 and 3, were also found to lower plasma glucose levels of genetically obese db/db and ob/ob mice with potency similar to that of ciglitazone. However, members from these series failed to lower insulin levels of the ob/ob mouse at the doses tested.
• WROEL, JAY E.
  作者：WROEL, JAY E.

  DOI：——

  日期：——